EDITORIAL
Published on 09 Sep 2022
Editorial: Cancer therapy: The challenge of handling a double-edged sword
doi 10.3389/fphar.2022.1007762
- 2,625 views
- 8 citations
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Cancer Therapy: The Challenge of Handling a Double-Edged Sword
Cancer Therapy: The Challenge of Handling a Double-Edged Sword
43k
Total downloads
160k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 28 Mar 2022
Mechanisms of Chemotherapy-Induced Neurotoxicity
doi 10.3389/fphar.2022.750507
- 24,103 views
- 101 citations
ORIGINAL RESEARCH
Published on 21 Jan 2022
Escape From Cisplatin-Induced Senescence of Hypoxic Lung Cancer Cells Can Be Overcome by Hydroxychloroquine
doi 10.3389/fonc.2021.738385
- 3,755 views
- 15 citations
SYSTEMATIC REVIEW
Published on 05 Jan 2022
A Systematic Review and Meta-Analysis of the Effectiveness of Neuroprotectants for Paclitaxel-Induced Peripheral Neuropathy
doi 10.3389/fonc.2021.763229
- 5,352 views
- 12 citations
ORIGINAL RESEARCH
Published on 03 Dec 2021
Insights Into Acute and Delayed Cisplatin-Induced Emesis From a Microelectrode Array, Radiotelemetry and Whole-Body Plethysmography Study of Suncus murinus (House Musk Shrew)
doi 10.3389/fphar.2021.746053
- 2,030 views
- 8 citations
ORIGINAL RESEARCH
Published on 29 Nov 2021
Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System
doi 10.3389/fphar.2021.720776
- 1,964 views
- 7 citations
ORIGINAL RESEARCH
Published on 22 Nov 2021
Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in First-Line Treatment for Advanced Soft Tissue Sarcoma: A Pooled Analysis of Randomized Trials
doi 10.3389/fonc.2021.762288
- 4,422 views
- 7 citations
MINI REVIEW
Published on 12 Nov 2021
Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment
doi 10.3389/fphar.2021.734613
- 3,258 views
- 11 citations
ORIGINAL RESEARCH
Published on 04 Nov 2021
Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy
doi 10.3389/fphar.2021.744085
- 2,487 views
- 5 citations
REVIEW
Published on 15 Oct 2021
Long-Term Effects of Pediatric Acute Lymphoblastic Leukemia Chemotherapy: Can Recent Findings Inform Old Strategies?
doi 10.3389/fonc.2021.710163
- 10,886 views
- 24 citations
CASE REPORT
Published on 13 Oct 2021
Case Report: Afatinib-Induced Interstitial Pneumonia: Experiences and Lessons From Two Patients
doi 10.3389/fphar.2021.698447
- 2,108 views
- 1 citation
SYSTEMATIC REVIEW
Published on 12 Oct 2021
Incidence and Risk of Hypertension in Cancer Patients Treated With Atezolizumab and Bevacizumab: A Systematic Review and Meta-Analysis
doi 10.3389/fonc.2021.726008
- 2,968 views
- 3 citations
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Gastrointestinal and Hepatic Pharmacology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 160kTopic views
- 115kArticle views
- 43kArticle downloads